Analysis of cytokines in tear fluid from atopic dermatitis patients with dupilumab-associated ocular adverse events

被引：3
|
作者：
Vuillemey, L. [1 ]
Febvay, C. [1 ]
Puzenat, E. [2 ]
Bellanger, A. P. [3 ]
Chague, C. [4 ]
Puyraveau, M. [5 ]
Delbosc, B. [1 ,4 ]
Gauthier, A. -S. [1 ,4 ]
Aubin, F. [2 ,4 ]
机构：
[1] CHU Besancon, Dept Ophthalmol, Besancon, France
[2] CHU Besancon, Dept Dermatol, Besancon, France
[3] CHU Besancon, Dept Parasitol, Besancon, France
[4] Univ Bourgogne Franche Comte, Federat Hosp Univ INCREASE, Interact Hote Greffon Tumeur Ingn Cellulaire & Ge, LabEx LipSTIC,INSERM,UMR1098,EFS BFC, Besancon, France
[5] CHU Besancon, Dept Clin Res, Besancon, France
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2022年 / 36卷 / 03期
关键词：
VERNAL KERATOCONJUNCTIVITIS; DISEASE;
D O I：
10.1111/jdv.17729
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E195 / E197
页数：3
相关论文
共 50 条
  • [41] Ocular Adverse Events in Patients With Atopic Dermatitis Treated With Upadacitinib: A Real-Life Experience
    Gelato, Federica
    Mastorino, Luca
    Quaglino, Pietro
    Cavaliere, Giovanni
    Ortoncelli, Michela
    Ribero, Simone
    DERMATITIS, 2023, : 445 - 447
  • [42] Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
    Li, Angelo
    Musters, Annelie H.
    Hyseni, Arienna
    Gerbens, Louise A. A.
    Spuls, Phyllis, I
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (06) : 1012 - 1013
  • [43] Tear function and ocular surface mucin alterations in atopic dermatitis patients
    Dogru, M
    Okada, N
    Kato, NA
    Igarashi, A
    Tanaka, M
    Takano, Y
    Fukagawa, K
    Tsubota, K
    Shimazaki, J
    Fujishima, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [44] New insights on ocular surface disease in patients with atopic dermatitis treated with dupilumab
    Bortoluzzi, P.
    Ferrucci, S.
    Galimberti, D.
    Garavelli, F.
    Pozzo Giuffrida, F.
    Pizzati, A.
    Marzano, A. V.
    Mapelli, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : 186 - 187
  • [45] Prophylactic use of diquafosol eye drops for dupilumab-associated conjunctivitis in patients with severe atopic dermatitis: An open-label prospective study
    Shin, Kihyuk
    Lee, Jin-Su
    Jeon, Hyeshin
    Lee, Gi-Wook
    Shin, Jun-Oh
    Roh, Dongyoung
    Kim, Yeona
    Won, Sang-Hyeon
    Lee, Jungsoo
    Kim, Hoon-Soo
    Kim, Byung-Soo
    Kim, Moon-Bum
    Ko, Hyun-Chang
    ALLERGY, 2024, 79 (03) : 746 - 748
  • [46] Conjunctivitis as adverse event during systemic dupilumab treatment in patients with atopic dermatitis
    van Luijk, C. M.
    Wisse, R. P. L.
    Hercegovac, A.
    Ariens, L.
    Bakker, D.
    Lans, A.
    Weller-de Bruijn, M.
    ACTA OPHTHALMOLOGICA, 2019, 97 : 3 - 4
  • [47] Conjunctivitis as adverse event during systemic dupilumab treatment in patients with atopic dermatitis
    van Luijk, C. M.
    Ariens, L.
    de Bruin-Weller, M. S.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 3 - 3
  • [48] Characterising the chronicity of dupilumab-associated ocular surface disease: an analysis of a retrospective case series
    Hebert, Melanie
    Qi, Susan Ruyu
    You, Eunice
    Mercier, Mathieu
    Laughrea, Patricia-Ann
    BMJ OPEN OPHTHALMOLOGY, 2022, 7 (01):
  • [49] PROPHYLACTIC USE OF DIQUAFOSOL EYE DROPS FOR DUPILUMAB-ASSOCIATED CONJUNCTIVITIS IN PATIENTS WITH SEVERE ATOPIC DERMATITIS: AN OPEN-LABEL PROSPECTIVE STUDY
    Shin, Kihyuk
    Lee, Jin-Su
    Jeon, Hyeshin
    Lee, Jungsoo
    Kim, Byungsoo
    Kim, Moon-Bum
    Ko, Hyunchang
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 32 - 32
  • [50] A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis
    Tsai, Jun-Hong
    Tsai, Tsen-Fang
    DERMATITIS, 2024, 35 (01) : 24 - 42
12345